Argenx's CEO on using FcRn to target IgG mediated autoimmune diseases
Tim Van Hauwermeiren describes the science behind argenx's success, the potential market potential, pipeline programs, and his thoughts on European biotech.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
.png){kind=logo}
The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants
bottom of page
Comments